Myelin basic protein binds to and inhibits the fibrillar assembly of Aβ42 in vitro

Biochemistry

Volumn 48, Issue 22, 2009, Pages 4720-4727

  Hoos, Michael D ^a   Ahmed, Mahiuddin ^a   Smith, Steven O ^a   Van Nostrand, William E ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER'S DISEASE; AMYLOID PLAQUES; BRAIN PARENCHYMA; CEREBRAL AMYLOID ANGIOPATHY; FIBRIL FORMATION; IN-VITRO; MYELIN BASIC PROTEIN; PRECURSOR PROTEINS; SECRETASE; SHOW THROUGH;

AMINO ACIDS; BLOOD VESSELS; BRAIN; GLYCOPROTEINS; ORGANIC ACIDS; PEPTIDES;

AMINES;

AMINO ACID; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; GAMMA SECRETASE; MYELIN BASIC PROTEIN;

ALZHEIMER DISEASE; ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; BETA SHEET; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CLEAVAGE; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SENILE PLAQUE; ULTRASTRUCTURE; VASCULAR AMYLOIDOSIS;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; AMYLOID BETA-PROTEIN; HUMANS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SENILE PLAQUES;

EID: 66649118037     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi900037s     Document Type: Article

References (45)

1. Selkoe, D. J. (2001) Alzheimer's disease: Genes, proteins, and therapy. Physiol. Rev. 81, 741-766.
2. Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K. H., Multhaup, G., Beyreuther, K., and Muller-Hill, B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736. (Pubitemid 17054046)
3. Goldgaber, D., Lerman, M. I., McBride, O. W., Saffiotti, U., and Gajdusek, D. C. (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235, 877-880. (Pubitemid 17019124)
4. Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., and Neve, R. L. (1987) Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235, 880-884.
5. Robakis, N. K., Ramakrishna, N., Wolfe, G., and Wisniewski, H. M. (1987) Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. Proc. Natl. Acad. Sci. U.S.A. 84, 4190-4194.
6. Roher, A. E., Lowenson, J. D., Clarke, S., Woods, A. S., Cotter, R. J., Gowing, E., and Ball, M. J. (1993) β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90, 10836-10840.
7. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., and Beyreuther, K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A. 82, 4245-4249.
8. Dolev, I., and Michaelson, D. M. (2006) The nucleation growth and reversibility of Amyloid-β deposition in vivo. J. Alzheimer's Dis. 10, 291-301. (Pubitemid 44763999)
9. McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M. P., Beard, J., Das, P., Jansen, K., Delucia, M., Lin, W. L., Dolios, G., Wang, R., Eckman, C. B., Dickson, D. W., Hutton, M., Hardy, J., and Golde, T. (2005) Aβ42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47, 191-199. (Pubitemid 41019251)
10. Findeis, M. A. (2007) The role of amyloid β peptide 42 in Alzheimer's disease. Pharmacol. Ther. 116, 266-286.
11. Vinters, H. V. (1987) Cerebral amyloid angiopathy. A critical review. Stroke 18, 311-324.
12. Jellinger, K. A. (2002) Alzheimer disease and cerebrovascular pathology: An update. J. Neural Transm. 109, 813-836. (Pubitemid 34810776)
13. Thal, D. R., Ghebremedhin, E., Orantes, M., and Wiestler, O. D. (2003) Vascular pathology in Alzheimer disease: Correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J. Neuropathol. Exp. Neurol. 62, 1287-1301.
14. Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T., Luyendijk, W., and Frangione, B. (1990) Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124-1126. (Pubitemid 20189869)
15. Van Broeckhoven, C., Haan, J., Bakker, E., Hardy, J. A., Van Hul, W., Wehnert, A., Vegter-Van der Vlis, M., and Roos, R. A. (1990) Amyloid β protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science 248, 1120-1122. (Pubitemid 20189867)
16. Hendriks, L., van Duijn, C. M., Cras, P., Cruts, M., Van Hul, W., van Harskamp, F., Warren, A., McInnis, M. G., Antonarakis, S. E., and Martin, J. J.; et al. (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nat. Genet. 1, 218-221.
17. Kamino, K., Orr, H. T., Payami, H., Wijsman, E. M., Alonso,M. E., Pulst, S. M.,Anderson, L.,O'Dahl, S.,Nemens, E., and White, J. A.; et al. (1992) Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am. J.Hum. Genet. 51, 998-1014.
18. Tagliavini, F., Rossi, G., Padovani, A., Magoni, M., Andora, G., Sgarzi, M., Bizzi, A., Savioardo, M., Carella, F., Morbin, M., Giaccone, G., and Bugiani, O. (1999) A new APP mutation related to hereditary cerebral hemorrhage. Alzheimer's Rep. 2, S28.
19. Grabowski, T. J., Cho, H. S., Vonsattel, J. P., Rebeck, G. W., and Greenberg, S. M. (2001) Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann. Neurol. 49, 697-705.
20. Davis, J., and Van Nostrand, W. E. (1996) Enhanced pathologic properties of Dutch-type mutant amyloid β-protein. Proc. Natl. Acad. Sci. U.S.A. 93, 2996-3000.
21. Verbeek, M. M., de Waal, R. M., Schipper, J. J., and Van Nostrand, W. E. (1997) Rapid degeneration of cultured human brain pericytes by amyloid β protein. J. Neurochem. 68, 1135-1141. (Pubitemid 27086218)
22. Miravalle, L., Tokuda, T., Chiarle, R., Giaccone, G., Bugiani, O., Tagliavini, F., Frangione, B., and Ghiso, J. (2000) Substitutions at codon 22 of Alzheimer's Aβ peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J. Biol. Chem. 275, 27110-27116.
23. Melchor, J. P., McVoy, L., and Van Nostrand, W. E. (2000) Charge alterations of E22 enhance the pathogenic properties of the amyloid β-protein. J. Neurochem. 74, 2209-2212. (Pubitemid 30217679)
24. Van Nostrand, W. E., Melchor, J. P., Cho, H. S., Greenberg, S. M., and Rebeck, G. W. (2001) Pathogenic effects of D23N Iowa mutant amyloid β-protein. J. Biol. Chem. 276, 32860-32866.
25. Hoos, M. D., Ahmed, M., Smith, S. O., and Van Nostrand, W. E. (2007) Inhibition of familial cerebral amyloid angiopathy mutant amyloid β-protein fibril assembly by myelin basic protein. J. Biol. Chem. 282, 9952-9961.
26. Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., and Glabe, C. (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267, 546-554.
27. Stine, W. B.Jr., Dahlgren, K. N., Krafft, G. A., and LaDu, M. J. (2003) In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278, 11612-11622.
28. Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., Berry, R., and Vassar, R. (2006) Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: Potential factors in amyloid plaque formation. J. Neurosci. 26, 10129-10140. (Pubitemid 44527407)
29. Nelson, R., and Eisenberg, D. (2006) Recent atomic models of amyloid fibril structure. Curr. Opin. Struct. Biol. 16, 260-265.
30. Harauz, G., Ishiyama, N., Hill, C. M., Bates, I. R., Libich, D. S., and Fares, C. (2004) Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis. Micron 35, 503-542. (Pubitemid 38836830)
31. Bartolini, M., Bertucci, C., Bolognesi, M. L., Cavalli, A., Melchiorre, C., and Andrisano, V. (2007) Insight into the kinetic of amyloid β (1-42) peptide self-aggregation: Elucidation of inhibitors' mechanism of action. ChemBioChem 8, 2152-2161.
32. Susi, H., and Byler, D. M. (1983) Protein structure by Fourier transform infrared spectroscopy: Second derivative spectra. Biochem. Biophys. Res. Commun. 115, 391-397.
33. Haris, P. I., and Chapman, D. (1994) Analysis of polypeptide and protein structures using Fourier transform infrared spectroscopy. Methods Mol. Biol. 22, 183-202.
34. Jackson, M., and Mantsch, H. H. (1995) The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit. Rev. Biochem. Mol. Biol. 30, 95-120.
35. Bitan, G., Kirkitadze, M. D., Lomakin, A., Vollers, S. S., Benedek, G. B., and Teplow, D. B. (2003) Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. U.S.A. 100, 330-335.
36. Hoshi, M., Sato, M., Matsumoto, S., Noguchi, A., Yasutake, K., Yoshida, N., and Sato, K. (2003) Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate τ protein kinase I/glycogen synthase kinase-3β. Proc. Natl. Acad. Sci. U.S.A. 100, 6370-6375.
37. Walsh, D. M., and Selkoe, D. J. (2007) Aβ oliogmers: A decade of discovery. J. Neurochem. 101, 1172-1184.
38. Haass, C., and Selkoe, D. J. (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid β peptide. Nat. Rev. Mol. Cell Biol. 8, 101-112.
39. DeKosky, S. T., Abrahamson, E. E., Ciallella, J. R., Paljug, W. R., Wisniewski, S. R., Clark, R. S., and Ikonomovic, M. D. (2007) Association of increased cortical soluble Aβ42 levels with diffuse plaques after severe brain injury in humans. Arch. Neurol. 64, 541-544.
40. Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C. M., Kim, G., Seekins, S., Yager, D., Slunt, H. H., Wang, R., Seeger, M., Levey, A. I., Gandy, S. E., Copeland, N. G., Jenkins, N. A., Price, D. L., Younkin, S. G., and Sisodia, S. S. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013. (Pubitemid 26424026)
41. Behrouz, N., Defossez, A., Delacourte, A., and Mazzuca, M. (1991) The immunohistochemical evidence of amyloid diffuse deposits as a pathological hallmark in Alzheimer's disease. J. Gerontol. 46, B209-B212.
42. Wisniewski, H. M., Bancher, C., Barcikowska, M., Wen, G. Y., and Currie, J. (1989) Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease. Acta Neuropathol. 78, 337-347. (Pubitemid 19200583)
43. Whitaker, J. N. (1998) Myelin basic protein in cerebrospinal fluid and other body fluids. Mult. Scler. 4, 16-21.
44. Papenfuss, T. L., Thrash, J. C., Danielson, P. E., Foye, P. E., Hllbrush, B. S., Sutcliffe, J. G., Whitacre, C. C., and Carson, M. J. (2007) Induction of Golli-MBP expression in CNS macrophages during acute LPS-induced CNS inflammation and experimental autoimmune encephalomyelitis (EAE). ScientificWorldJournal 7, 112-120. (Pubitemid 350277592)
45. Filipovic, R., and Zecevic, N. (2005) Lipopolysaccharide affects Golli expression and promotes proliferation of oligodendrocyte progenitors. Glia 49, 457-466. (Pubitemid 40353832)